XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
New Accounting Pronouncement Early Adoption Effect
Additional Paid-in Capital [Member]
New Accounting Pronouncement Early Adoption Effect
Retained Earnings [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss)
Retained Earnings [Member]
Total
Balance at beginning of period at Dec. 31, 2015         $ (79,399)    
Net income (loss)             $ (32,822,796)
Unrealized loss on securities             111,039
Balance at end of period at Sep. 30, 2016         31,640    
Balance at beginning of period at Jun. 30, 2016         96,246    
Net income (loss)             (8,707,396)
Unrealized loss on securities             (64,606)
Balance at end of period at Sep. 30, 2016         31,640    
Reclassification of impact of ASU 2016-09 (See Note 3) | ASU 2016-09 $ 267,824 $ (267,824)          
Balance after adjustment     $ 42,378 $ 391,036,566 (41,196) $ (253,890,385) 137,147,363
Balance at beginning of period (Previously Reported) at Dec. 31, 2016     $ 42,378 390,768,742 (41,196) (253,622,561) 137,147,363
Balance at beginning of period at Dec. 31, 2016         (41,196)   137,147,363
Balances (in shares) (Previously Reported) at Dec. 31, 2016     42,377,522        
Balances (in shares) at Dec. 31, 2016     42,377,522        
Exercise of stock options     $ 52 109,690     109,742
Exercise of stock options (in shares)     52,258        
Stock-based compensation     $ 115 2,586,131     2,586,246
Stock-based compensation (in shares)     114,365        
Employee stock purchase plan     $ 37 48,370     48,407
Issuance of common stock in connection with development and license agreement     $ 2,000 2,818,000     2,820,000
Issuance of common stock in connection with development and license agreement (in shares)     2,000,000        
Issuance of common stock in connection with exercise of warrant to purchase common stock     $ 3,278 5,501,925     5,505,203
Issuance of common stock in connection with exercise of warrant to purchase common stock (in shares)     3,278,000        
Number of shares purchased under ESPP     37,236        
Net income (loss)           (46,500,131) (46,500,131)
Unrealized loss on securities         36,636   36,636
Balance at end of period at Sep. 30, 2017     $ 47,860 402,100,682 (4,560) (300,390,516) $ 101,753,466
Balances (in shares) at Sep. 30, 2017     47,859,381        
Balance at beginning of period at Jun. 30, 2017         (34,863)    
Exercise of stock options (in shares)             0
Net income (loss)             $ (23,266,818)
Unrealized loss on securities             30,303
Balance at end of period at Sep. 30, 2017     $ 47,860 $ 402,100,682 $ (4,560) $ (300,390,516) $ 101,753,466
Balances (in shares) at Sep. 30, 2017     47,859,381